Coexistence of neuromodulators: biochemical and pharmacological consequences
Costa, E.
Federation Proceedings 42(12): 2910-2911
1983
ISSN/ISBN: 0014-9446 PMID: 6136424 Document Number: 215168
Document emailed within 1 workday
Related Documents
Rüther, E.; Davis, L.; Papousek, M.; Reichinger, M.; Reiter, H.; Rudolph, M. 1976: Pharmacological influence on central serotonergic mechanisms in man and its consequences on sleep Arzneimittel-Forschung 26(6): 1071-1073Meistelman, C.; Barre, J.; Viars, P.; Tillement, J.P. 1984: Plasma binding of drugs. Pharmacological consequences and applications to anesthesia Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 25(10): 1125-1129
Cleland, J.G. 1998: Health economic consequences of the pharmacological treatment of heart failure European Heart Journal 19 Suppl P: P32-P39
White, L.W.; Levy, R.P.; Anton, A.H. 1973: Comparison of biochemical and pharmacological testing for pheochromocytoma Research Communications in Chemical Pathology and Pharmacology 5(1): 252-262
Markwardt, F. 1976: Biochemical and pharmacological principles of antithrombotic therapy Folia Haematologica 103(3): 293-312
Scuvée-Moreau, J.; Dresse, A. 1982: Monoamines and endogenous depression. Biochemical and pharmacological aspects Revue Medicale de Liege 37(1): 1-7
Walsmann, P.; Markwardt, F. 1981: Biochemical and pharmacological aspects of the thrombin inhibitor hirudin Die Pharmazie 36(10): 653-660
Fox, D.A. 1982: Pharmacological and biochemical evaluation of triethyltin's anticonvulsant effects Neurobehavioral Toxicology and Teratology 4(2): 273-278
Layzer, R.B.; Havel, R.J.; McIlroy, M.B. 1980: Partial deficiency of carnitine palmityltransferase: physiologic and biochemical consequences Neurology 30(6): 627-633
Dlohozková, N.; Metys, J.; Valchár, M.; Soucek, R. 1989: Biochemical pharmacological profile of migraine prophylactics of pizotifen type Activitas Nervosa Superior 31(4): 300-301
Mascitelli-Coriandoli, E.; Fraia, A. 1970: Prednacinolone, a new anti-inflammatory steroid. 2. Biochemical and pharmacological properties Arzneimittel-Forschung 20(1): 111-115
David, J.; Kaul, C.L.; Grewal, R.S. 1979: Pharmacological & biochemical characterization of antiparkinson drugs in reserpinized mice Indian Journal of Experimental Biology 17(8): 760-764
Hyttel, J.; Christensen, A.V. 1983: Biochemical and pharmacological differentiation of neuroleptic effect on dopamine D-1 and D-2 receptors Journal of Neural Transmission. Supplementum 18: 157-164
Rybakowski, J. 1986: Mechanisms of alcohol dependence in the light of biochemical and pharmacological studies Psychiatria Polska 20(1): 58-66
Montastruc, J.L.; Senard, J.M.; Rascol, O.; Rascol, A. 1996: Autonomic nervous system dysfunction and adrenoceptor regulation in Parkinson's disease. Clinical and pharmacological consequences Advances in Neurology 69: 377-381
Rangoonwala, B.; Rosenthal, I. 1998: Management of hypertension and its sequelae with ACE inhibitors: biochemical, pharmacological and clinical aspects International Journal of Clinical Practice 52(7): 492-500
Bouclier, M.; Hensby, C.N. 1986: Biochemical, pharmacological and therapeutic aspects of skin metabolism of arachidonic acid Annales de Dermatologie et de Venereologie 113(12): 1289-1293
Kalbhen, D.A. 1978: The biochemical and pharmacological basis of the anti-phlogistic/antirheumatic effect of pentosan polysulfate Wiener Klinische Wochenschrift 90(3): 101-105
Hensler, J.G.; Cotterell, D.J.; Dubocovich, M.L. 1987: Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina Journal of Pharmacology and Experimental Therapeutics 243(3): 857-867
Patrignani, P.; Panara, M.R.; Greco, A.; Fusco, O.; Natoli, C.; Iacobelli, S.; Cipollone, F.; Ganci, A.; Créminon, C.; Maclouf, J. 1994: Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases Journal of Pharmacology and Experimental Therapeutics 271(3): 1705-1712